MetaCap

CeriBell (CBLL) vs Vivani Medical (VANI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CeriBell (CBLL) has outperformed Vivani Medical (VANI) over the past year, gaining 79.5% versus a loss of 13.6%. CeriBell is the larger company by market cap ($1.06 billion vs $102.8 million), about 10.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CBLL+79.49%VANI-13.64%
+91%+28%-35%
Nov 21, 20251 yearNov 20, 2026
CBLL+9.56%VANI+0.88%
+55%-2%-60%
Oct 7, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CBLL versus VANI key metrics
MetricCBLLVANI
Share price$27.39$1.14
Market cap$1.06B$102.83M
1-day change+6.37%+4.59%
YTD return+24.90%-7.32%
1-year return+79.49%-13.64%
5-year return—-81.82%
EPS (TTM)$-1.95$-0.33
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$89.06M$0
Revenue growth (YoY)+36.09%—
Net income (latest FY)$-53.41M$-26.61M
Gross margin87.89%—
Operating margin-65.57%—
Net margin-59.97%—
52-week high$28.89$1.66
52-week low$14.87$0.80
Distance from 52-week high-5.19%-31.37%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+15.26%+235.96%
Average volume452.64K228.83K
Shares outstanding38.84M90.20M
Employees32742
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CeriBell is about 10.3 times larger than Vivani Medical by market value ($1.06B vs $102.83M).
  • CBLL has outperformed VANI by 93.1 percentage points over the past year.

About CeriBell

CBLL stock →

CeriBell, Inc. operates as a medical technology company in the United States.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees

About Vivani Medical

VANI stock →

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees

CBLL vs VANI FAQ

Which is bigger, CeriBell or Vivani Medical?

CeriBell (CBLL) is larger, with a market capitalization of $1.06B compared with $102.83M for Vivani Medical (VANI).

Which stock has performed better over the past year, CBLL or VANI?

CBLL returned +79.49% over the past 12 months, compared with -13.64% for VANI (price return, excluding dividends). Past performance does not predict future results.

Are CeriBell and Vivani Medical in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons